The Potential Economic Value of a Staphylococcus Aureus Vaccine Among Hemodialysis Patients

Vaccine - Netherlands
doi 10.1016/j.vaccine.2012.03.031
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Would Hemodialysis Patients Benefit From a Staphylococcus Aureus Vaccine?

Kidney International
Nephrology
2019English

The Economic Value of Screening Haemodialysis Patients for Methicillin-Resistant Staphylococcus Aureus in the USA

Clinical Microbiology and Infection
MedicineInfectious DiseasesMicrobiology
2011English

Methicillin Resistance in Staphylococcus Aureus Infections Among Patients Colonized With Methicillin-Susceptible Staphylococcus Aureus

Clinical Microbiology and Infection
MedicineInfectious DiseasesMicrobiology
2019English

Methicillin-Resistant Staphylococcus Aureus Nasal Carriage Among Patients Receiving Hemodialysis in Taiwan: Prevalence Rate, Molecular Characterization and De-Colonization

BMC Infectious Diseases
Infectious Diseases
2012English

Development of a Mimotope Vaccine Targeting the Staphylococcus Aureus Quorum Sensing Pathway

PLoS ONE
Multidisciplinary
2014English

593 Clustering of Staphylococcus Aureus (Sa) Infections in a Pediatric Hemodialysis (Hmd) Unit

Pediatric Research
Child HealthPediatricsPerinatology
1985English

Antimicrobial Activity of Daptomycin and Selected Comparators Tested Against Bloodstream Staphylococcus Aureus Isolates From Hemodialysis Patients

International Journal of Infectious Diseases
MedicineInfectious DiseasesMicrobiology
2009English

Covering All the Bases: Preclinical Development of an Effective Staphylococcus Aureus Vaccine

Frontiers in Immunology
AllergyImmunology
2014English

Developing a Universal Staphylococcus Aureus Vaccine: Why Aren?t We There Yet?

Internal Medicine: Open Access
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy